RS CRUM INC. CLDI — CALIDI BIOTHERAPEUTICS INC

Ownership history in RS CRUM INC.  ·  5 quarters on record

AI Ownership Summary

RS CRUM INC. reported CALIDI BIOTHERAPEUTICS INC (CLDI) in 5 quarterly 13F filings from 2024 Q4 through 2026 Q1. Peak portfolio weight reached 0.01% in 2024 Q4. The latest visible filing shows CLDI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CLDI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was RS CRUM INC.'s position in CALIDI BIOTHERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CLDI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CLDI stock page RS CRUM INC. fund profile RS CRUM INC. full holdings
How RS CRUM INC. held CLDI — position size vs. price
% of Fund (quarterly)    CLDI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 40,256 +20,000 +98.7% 0.00% $10K 2026-04-15 $0.27
2025 Q4 ADDED — — — 20,256 +5,000 +32.8% 0.00% $24K 2026-02-17 $0.75
2025 Q3 REDUCED 72.4% -21.7% ✅ 15,256 -40,057 -72.4% 0.01% $23K 2025-11-12 $1.51
2025 Q1 ADDED — — — 55,313 +14,850 +36.7% 0.01% $31K 2025-04-17 $5.56
2024 Q4 INITIATED — — — 40,463 — — 0.01% $47K 2025-02-10 $15.84

🏢 Other funds also holding CLDI

As of 2026 Q1 — sorted by position size

SABBY MANAGEMENT, LLC 3Y 7Y 0.23% Warberg Asset Management LLC 3Y 0.01% ARMISTICE CAPITAL, LLC 3Y 7Y 0.0% Virtu Financial LLC 3Y 7Y 0.0% Arax Advisory Partners 3Y 7Y 0.0% Belpointe Asset Management LLC 3Y 7Y 0.0% Farther Finance Advisors, LLC 0.0% HighTower Advisors, LLC 3Y 7Y 0.0% Reyes Financial Architecture, Inc. 0.0% Finepoint Capital LP 3Y 7Y 0.0%

FAQ About RS CRUM INC. and CLDI

These are the practical questions this page is built to answer before you even open the full history table.

How long has RS CRUM INC. reported owning CLDI?

RS CRUM INC. reported CLDI across 5 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported CLDI position in RS CRUM INC.'s portfolio?

The largest reported portfolio weight for CLDI was 0.01% in 2024 Q4.

What is the latest reported CLDI position on this page?

The most recent filing on this page is 2026 Q1, when RS CRUM INC. reported 40,256 shares, equal to 0.00% of portfolio, with an estimated market value of $10K.

What does the chart on this CLDI ownership page compare?

The chart compares RS CRUM INC.'s quarterly CLDI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did RS CRUM INC. time their CLDI position?

Based on 13F filing dates vs. subsequent CLDI price moves, RS CRUM INC. correctly timed 1 out of 4 reported position changes (25%). The annualised alpha on CLDI relative to SPY over the holding period was -97.3%.

← Back to RS CRUM INC. Holdings